Market Overview:
The global discovery bioanalysis market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for target identification and validation services, rising R&D expenditure by pharmaceutical and biotechnology companies, and growing number of drug approvals. The global discovery bioanalysis market is segmented on the basis of type into small molecules, large molecules, and vaccines. The small molecules segment is expected to account for the largest share of the global discovery bioanalysis market in 2018. This segment is also projected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030.
Product Definition:
Discovery Bioanalysis is the analysis of small molecules and proteins in biological samples. This type of analysis is important for drug discovery and development, as it can help identify potential drug targets and biomarkers.
Small Molecules:
Small molecules are organic or inorganic chemicals. They can be gases, liquids or solids at room temperature. Small molecules include alcohols, ketones, aldehydes and others which have molecular weight less than 1000. The most commonly used small molecule is ethanol (alcohol). Other important small molecules for discovery bioanalysis market are acetone (methyl ethyl ketone), methanol (methyl alcohol) and acetic acid (formaldehyde).
Large Molecules:
Large molecules are organic or inorganic compounds with a molecular weight greater than 1000. The most commonly used large molecule is DNA (deoxyribonucleic acid) because it can be extracted from any biological sample and its quantity can be measured using a variety of techniques.
DNA is the genetic material that carries the instructions needed to build every tissue, organ, and body structure in organisms. It also stores information about hereditary patterns for diseases and health problems.
Application Insights:
The others application segment dominated the global discovery bioanalysis market in 2017, accounting for over 40% of the overall revenue. The other applications include academic research and drug development. Increasing R&D costs coupled with a growing need to reduce healthcare expenditure is driving pharmaceutical companies to outsource drug discovery programs to biotechnology companies and institutions that offer bioanalytical services at reduced cost.
Pharmaceutical companies are increasingly collaborating with biotechnology firms as they offer advanced solutions for discovering novel drugs by integrating biological data with chemical information through bioinformatics tools. This has led to an increase in outsourcing of clinical trials which was previously done by the pharmaceutical company itself or its partners overseas (e.g., United States).
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of biotechnology and pharmaceutical companies, coupled with high R&D investment by these firms, has contributed to North America’s dominance. In addition, increasing government funding for disease-related research is also expected to propel the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as improving healthcare infrastructure and growing investments by various governments in emerging markets such as China and India. Furthermore, an increase in disposable income levels will boost demand for medical services leading to greater adoption of diagnostic techniques such as bioanalysis across this region.
Growth Factors:
- Increasing demand for personalized medicines
- Growing number of biotechnology and pharmaceutical companies
- Rising prevalence of chronic diseases
- Technological advancements in bioanalysis instruments and methods
- Growing awareness about the benefits of early diagnosis
Scope Of The Report
Report Attributes
Report Details
Report Title
Discovery Bioanalysis Market Research Report
By Type
Small Molecules, Large Molecules, Vaccines
By Application
Pharmaceutical Companies, Biotechnology Companies, Others
By Companies
WuXi AppTec, Charles River, Covance, Eurofins Scientific, ICON, Bio-Rad Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Discovery Bioanalysis Market Report Segments:
The global Discovery Bioanalysis market is segmented on the basis of:
Types
Small Molecules, Large Molecules, Vaccines
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Companies, Biotechnology Companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- WuXi AppTec
- Charles River
- Covance
- Eurofins Scientific
- ICON
- Bio-Rad Laboratories
Highlights of The Discovery Bioanalysis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Small Molecules
- Large Molecules
- Vaccines
- By Application:
- Pharmaceutical Companies
- Biotechnology Companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Discovery Bioanalysis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Discovery Bioanalysis is a molecular diagnostics company that provides genetic testing and interpretation services to the healthcare industry. The company's products include whole-genome sequencing, next-generation sequencing, and gene expression analysis. Discovery Bioanalysis also offers consulting services to help clients identify disease risks and develop treatment plans.
Some of the major companies in the discovery bioanalysis market are WuXi AppTec, Charles River, Covance, Eurofins Scientific, ICON, Bio-Rad Laboratories.
The discovery bioanalysis market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Discovery Bioanalysis Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Discovery Bioanalysis Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Discovery Bioanalysis Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Discovery Bioanalysis Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Discovery Bioanalysis Market Size & Forecast, 2018-2028
4.5.1 Discovery Bioanalysis Market Size and Y-o-Y Growth
4.5.2 Discovery Bioanalysis Market Absolute $ Opportunity
Chapter 5 Global Discovery Bioanalysis Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Discovery Bioanalysis Market Size Forecast by Type
5.2.1 Small Molecules
5.2.2 Large Molecules
5.2.3 Vaccines
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Discovery Bioanalysis Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Discovery Bioanalysis Market Size Forecast by Applications
6.2.1 Pharmaceutical Companies
6.2.2 Biotechnology Companies
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Discovery Bioanalysis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Discovery Bioanalysis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Discovery Bioanalysis Analysis and Forecast
9.1 Introduction
9.2 North America Discovery Bioanalysis Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Discovery Bioanalysis Market Size Forecast by Type
9.6.1 Small Molecules
9.6.2 Large Molecules
9.6.3 Vaccines
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Discovery Bioanalysis Market Size Forecast by Applications
9.10.1 Pharmaceutical Companies
9.10.2 Biotechnology Companies
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Discovery Bioanalysis Analysis and Forecast
10.1 Introduction
10.2 Europe Discovery Bioanalysis Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Discovery Bioanalysis Market Size Forecast by Type
10.6.1 Small Molecules
10.6.2 Large Molecules
10.6.3 Vaccines
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Discovery Bioanalysis Market Size Forecast by Applications
10.10.1 Pharmaceutical Companies
10.10.2 Biotechnology Companies
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Discovery Bioanalysis Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Discovery Bioanalysis Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Discovery Bioanalysis Market Size Forecast by Type
11.6.1 Small Molecules
11.6.2 Large Molecules
11.6.3 Vaccines
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Discovery Bioanalysis Market Size Forecast by Applications
11.10.1 Pharmaceutical Companies
11.10.2 Biotechnology Companies
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Discovery Bioanalysis Analysis and Forecast
12.1 Introduction
12.2 Latin America Discovery Bioanalysis Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Discovery Bioanalysis Market Size Forecast by Type
12.6.1 Small Molecules
12.6.2 Large Molecules
12.6.3 Vaccines
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Discovery Bioanalysis Market Size Forecast by Applications
12.10.1 Pharmaceutical Companies
12.10.2 Biotechnology Companies
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Discovery Bioanalysis Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Discovery Bioanalysis Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Discovery Bioanalysis Market Size Forecast by Type
13.6.1 Small Molecules
13.6.2 Large Molecules
13.6.3 Vaccines
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Discovery Bioanalysis Market Size Forecast by Applications
13.10.1 Pharmaceutical Companies
13.10.2 Biotechnology Companies
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Discovery Bioanalysis Market: Competitive Dashboard
14.2 Global Discovery Bioanalysis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 WuXi AppTec
14.3.2 Charles River
14.3.3 Covance
14.3.4 Eurofins Scientific
14.3.5 ICON
14.3.6 Bio-Rad Laboratories
